Binary pan-cancer classes with distinct
WebAug 9, 2024 · The binary cancer groups exhibit distinct YAP-dependent adhesive behavior and pharmaceutical vulnerabilities, underscoring clinical relevance. Mechanistically, … WebFigure 1. Features and mechanisms underlying binary YAPon and YAPoff cancer superclasses. (a) Features of YAP/TAZ-deficient (YAPoff) and YAP/TAZ-positive …
Binary pan-cancer classes with distinct
Did you know?
WebSep 24, 2024 · Here, we define pan-cancer binary classes based on distinct expression of YAP and YAP-responsive adhesion regulators. WebMD, PhD. Pulmonary Pathologist, Division of Pathology & Laboratory Medicine. Director, Pathology Research Core. Professor, UC Department of Pathology and Laboratory Medicine. [email protected]. Board Certified. Kathryn A. Wikenheiser-Brokamp, MD, PhD About Education and Training Publications Patient …
WebSep 24, 2024 · Features and mechanisms underlying binary YAP on and YAP off cancer superclasses. (a) Features of YAP/TAZ-deficient (YAP off) and YAP/TAZ-positive (YAP on) cancer classes, including the types, genetic and phenotypic characteristics, and key vulnerabilities.(b) Opposite anti- versus pro-oncogenic YAP/TEAD functions in YAP off … WebSep 24, 2024 · The YAP off class consisted of virtually all blood cancers (leukemia, lymphoma, and myeloma), many neural cancers (retinoblastoma, low-grade glioma, …
WebOct 21, 2024 · We showed the binary cancer classes have distinct drug sensitivities. Thus, drugs that are effective against YAP-deficient cancers are not effective against YAP-positive cancers, and vice versa. ... We didn’t set out to discover a pan-cancer rule. We were trying to understand why defects in a tumour suppressor gene called RB1 causes … WebBinary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity. J. Pearson, Katherine Huang, +23 authors R. Bremner; Biology, …
WebBinary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity. Pearson JD, Huang K, Pacal M, McCurdy SR, Lu S, Aubry A, Yu …
WebBinary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity. Cancer Cell, 39(8), 1115–1134.e12. doi:10.1016/j.ccell.2024.06.016 green golf club head coversWebJul 19, 2024 · Reference: Pearson JD, Huang K, Pacal M, et al. Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity. Cancer Cell. 2024. doi: 10.1016/j.ccell.2024.06.016 This article has been republished from the following materials. Note: material may have been edited for length and content. fluthilfe caritas euskirchenWebFigure 1. Features and mechanisms underlying binary YAP on and YAP off cancer superclasses. (a) Features of YAP/TAZ-deficient (YAP off) and YAP/TAZ-positive (YAP on) cancer classes, including the types, genetic and phenotypic characteristics, and key vulnerabilities.(b) Opposite anti- versus pro-oncogenic YAP/TEAD functions in YAP off … fluthiacet methyl mass spectrumWebSep 22, 2024 · Cancer heterogeneity impacts therapeutic response, driving efforts to discover over-arching rules that supersede variability. Here, we define pan-cancer binary classes based on distinct expression of YAP and YAP-responsive adhesion regulators. Combining informatics with in vivo and in vitro gain-and loss-of-function studies across … fluthilfemedaille 2021 nrwWebMay 7, 2024 · Colorectal cancer (CRC) is a common gastrointestinal malignancy, which is the third most commonly diagnosed cancer in males and the second one in females worldwide 1.Yes-associated protein (YAP ... green golf head coversWebHere, we define pan-cancer binary classes based on distinct expression of YAP and YAP-responsive adhesion regulators. Combining informatics with in vivo and in vitro gain- and loss-of-function studies across multiple murine and human tumor types, we show that opposite pro- or anti-cancer YAP activity functionally defines binary YAPon or YAPoff ... fluthiacet methyl herbicide trade nameWebJul 8, 2024 · Small-cell neuroendocrine cancers (SCNCs) are an aggressive cancer subtype. Transdifferentiation toward an SCN phenotype has been reported as a resistance route in response to targeted therapies. Here, we identified a convergence to an SCN state that is widespread across epithelial cancers and is as … fluthiacet seizure medication